- Home
- Industry Reports
- Healthcare
- Healthcare IT
- Middle East and Africa Topical Drug Delivery Market – Size, Trends and Forecast (2024 – 2032)
The topical drug is a type of drug that is applied to a particular place on the body mostly on the body surfaces like skin and mucous membranes to treat the ailments. Many of these drugs are applied directly to the skin and also be inhalational such as asthma medications. Some of them are applied on the surface of the tissues other than the skin such as eardrops placed on the ear or eye drops placed on the conjunctiva or medications applied to the surface of the tooth.
The Middle East and Africa Topical Drug Delivery Market Segments Size and Growth:
The Middle East and Africa Topical Drug Delivery market size are projected to reach approximately $ XX billion by the end of 2024 with a CAGR close to X% from $XX billion in 2018 during the forecast timeline 2018-2024. Key parameters prompting the topical drug delivery market growth include a high incidence of burn injuries, increasing geriatric population and also the growing prevalence of diabetes. As there is an increase in the geriatric population, the usage of the tropical drugs for treatment also increased. Therefore, many industries and firms were trying to increase the production of the tropical drugs in many regions
The Middle East and Africa Topical Drug Delivery Market Segment Share:
The Middle East and Africa Topical Drug Delivery market are divided based on various parameters. By the Product, they are divided into Solid, Semi-solid, Liquid and Devices. Among them, Transdermal drug delivery is expected to offer lucrative growth opportunities in the market because it provides therapeutic efficiency and helps to maintain a steady plasma level of the drug. By the Administration, they are divided into Skin, Vaginal, Oral Topical, Nasal, and Dermal. Among them, Skin has the most significant market due to increase in some skin diseases and increase in some product approval related to Skin-Related Drug Delivery. By the Facility of use, they are divided into Hospitals, Private Clinics, and Homecare settings. Among them, Hospital sector has the most significant market due to increase in some diseases and number of hospitals. Geography, Israel has the most significant market due to the presence of world largest pharmaceuticals in that region.
The Middle East and Africa Topical Drug Delivery Market Trends:
- ViiV Healthcare starts third phase III HIV treatment study investigating long-acting two-drug regimen of cabotegravir plus rilpivirine.
- GSK presents positive results from phase III revaccination of its candidate shingles vaccine shingix at CDC’s.
- Galderma announces enrolment of the first patient in phase IIb Nemolizumab trail in atopic dermatics.
The Middle East and Africa Topical Drug Delivery Market Research Report Includes:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary key players are:
- Glaxosmithkline
- Galderma
- Valeant Pharmaceuticals
- Hisamitsu Pharmaceuticals
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Overview
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analysis
4. Market Dynamics
4.1 Drivers
4.1.1 Ease of Drug Delivery
4.1.2 High Prevalence of Skin Diseases
4.2 Restraints
4.2.1 High Frequency of Product Recalls
4.2.2 Stringent Approval Process
4.3 Opportunities
4.3.1 Power of Suppliers
4.3.2 Power of Consumers
4.4 Challenges
4.4.1 Providing Suitable Medicine
5. Middle East and Africa Topical Drug Delivery Market – By Product
5.1 Formulation
5.1.1 Liquid
5.1.1.1 Solution
5.1.1.2 Suspension
5.1.2 Semi-Solid
5.1.2.1 Ointment
5.1.2.2 Gel
5.1.2.3 Paste
5.1.2.4 Cream & Lotion
5.1.3 Solid
5.1.3.1 Powder
5.2 Device
5.2.1 Patch
5.2.2 Inhaler
5.2.3 Transdermal Drug Delivery
6. Middle East and Africa Topical Drug Delivery Market – By Administration
6.1 Vaginal
6.2 Oral topical
6.3 Ophthalmic
6.4 Nasal
6.5 Dermal
6.6 Skin
6.7 Others
7. Middle East and Africa Topical Drug Delivery Market – By Facility of Use
7.1 Hospitals
7.2 Private Clinics
7.3 Home Care Settings
7.4 Others
8. Middle East and Africa Topical Drug Delivery Market – By Country
8.1 Middle East
8.2.2 Africa
9. Middle East and Africa Topical Drug Delivery Market – By Company Profiles
9.1 GlaxoSmithKline
9.2 Galderma
9.3 Valeant Pharmaceuticals
9.4 Hisamitsu Pharmaceuticals
9.5 Medpharma
9.6 Antares Pharma
9.7 Pfizer
9.8 Becton, Dickinson and Company
9.9 Merck & Co., INC
9.10 Johnson & Johnson Services., INC
9.11 Mylan Pharmaceutical Company
9.12 Neopharma LLC
9.13 CPHL
9.14 Labvantage Solutions
9.15 Ethicon
10. Middle East and Africa Topical Drug Delivery Market – By Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,014.93 - €6,716.42
- INR: ₹179,964.07 - ₹599,880.22
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,726.29 - £5,754.29
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
The topical drug is a type of drug that is applied to a particular place on the body mostly on the body surfaces like skin and mucous membranes to treat the ailments. Many of these drugs are applied directly to the skin and also be inhalational such as asthma medications. Some of them are applied on the surface of the tissues other than the skin such as eardrops placed on the ear or eye drops placed on the conjunctiva or medications applied to the surface of the tooth.
The Middle East and Africa Topical Drug Delivery Market Segments Size and Growth:
The Middle East and Africa Topical Drug Delivery market size are projected to reach approximately $ XX billion by the end of 2024 with a CAGR close to X% from $XX billion in 2018 during the forecast timeline 2018-2024. Key parameters prompting the topical drug delivery market growth include a high incidence of burn injuries, increasing geriatric population and also the growing prevalence of diabetes. As there is an increase in the geriatric population, the usage of the tropical drugs for treatment also increased. Therefore, many industries and firms were trying to increase the production of the tropical drugs in many regions
The Middle East and Africa Topical Drug Delivery Market Segment Share:
The Middle East and Africa Topical Drug Delivery market are divided based on various parameters. By the Product, they are divided into Solid, Semi-solid, Liquid and Devices. Among them, Transdermal drug delivery is expected to offer lucrative growth opportunities in the market because it provides therapeutic efficiency and helps to maintain a steady plasma level of the drug. By the Administration, they are divided into Skin, Vaginal, Oral Topical, Nasal, and Dermal. Among them, Skin has the most significant market due to increase in some skin diseases and increase in some product approval related to Skin-Related Drug Delivery. By the Facility of use, they are divided into Hospitals, Private Clinics, and Homecare settings. Among them, Hospital sector has the most significant market due to increase in some diseases and number of hospitals. Geography, Israel has the most significant market due to the presence of world largest pharmaceuticals in that region.
The Middle East and Africa Topical Drug Delivery Market Trends:
- ViiV Healthcare starts third phase III HIV treatment study investigating long-acting two-drug regimen of cabotegravir plus rilpivirine.
- GSK presents positive results from phase III revaccination of its candidate shingles vaccine shingix at CDC’s.
- Galderma announces enrolment of the first patient in phase IIb Nemolizumab trail in atopic dermatics.
The Middle East and Africa Topical Drug Delivery Market Research Report Includes:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary key players are:
- Glaxosmithkline
- Galderma
- Valeant Pharmaceuticals
- Hisamitsu Pharmaceuticals
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Overview
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analysis
4. Market Dynamics
4.1 Drivers
4.1.1 Ease of Drug Delivery
4.1.2 High Prevalence of Skin Diseases
4.2 Restraints
4.2.1 High Frequency of Product Recalls
4.2.2 Stringent Approval Process
4.3 Opportunities
4.3.1 Power of Suppliers
4.3.2 Power of Consumers
4.4 Challenges
4.4.1 Providing Suitable Medicine
5. Middle East and Africa Topical Drug Delivery Market – By Product
5.1 Formulation
5.1.1 Liquid
5.1.1.1 Solution
5.1.1.2 Suspension
5.1.2 Semi-Solid
5.1.2.1 Ointment
5.1.2.2 Gel
5.1.2.3 Paste
5.1.2.4 Cream & Lotion
5.1.3 Solid
5.1.3.1 Powder
5.2 Device
5.2.1 Patch
5.2.2 Inhaler
5.2.3 Transdermal Drug Delivery
6. Middle East and Africa Topical Drug Delivery Market – By Administration
6.1 Vaginal
6.2 Oral topical
6.3 Ophthalmic
6.4 Nasal
6.5 Dermal
6.6 Skin
6.7 Others
7. Middle East and Africa Topical Drug Delivery Market – By Facility of Use
7.1 Hospitals
7.2 Private Clinics
7.3 Home Care Settings
7.4 Others
8. Middle East and Africa Topical Drug Delivery Market – By Country
8.1 Middle East
8.2.2 Africa
9. Middle East and Africa Topical Drug Delivery Market – By Company Profiles
9.1 GlaxoSmithKline
9.2 Galderma
9.3 Valeant Pharmaceuticals
9.4 Hisamitsu Pharmaceuticals
9.5 Medpharma
9.6 Antares Pharma
9.7 Pfizer
9.8 Becton, Dickinson and Company
9.9 Merck & Co., INC
9.10 Johnson & Johnson Services., INC
9.11 Mylan Pharmaceutical Company
9.12 Neopharma LLC
9.13 CPHL
9.14 Labvantage Solutions
9.15 Ethicon
10. Middle East and Africa Topical Drug Delivery Market – By Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.